The Influence of Moisturizer Co-Application Protocols on In Vitro Penetration of Betamethasone in Porcine Skin

The Influence of Moisturizer Co-Application Protocols on In Vitro Penetration of Betamethasone in Porcine Skin

<b>Background/Objectives:</b> The treatment of atopic dermatitis frequently involves using a topical corticosteroid and a moisturizer. While the sequential application of these products is a common dermatological practice, their influence on drug penetration remains poorly understood. Th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Daiane L. Rost, Geisa N. Barbalho, Jayanaraian F. M. Andrade, Marcilio Cunha-Filho, Guilherme M. Gelfuso, Tais Gratieri
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Pharmaceutics
Subjects:	atopic dermatitis betamethasone dipropionate cutaneous drug delivery moisturizers topical corticosteroids
Online Access:	https://www.mdpi.com/1999-4923/17/7/874
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Utility of Various Formulations of Calcipotriene and Betamethasone Dipropionate for the Treatment of Plaque Psoriasis in Patients Aged 12 Years or Older
by: Kędra K, et al.
Published: (2024-12-01)

Patient Satisfaction with Calcipotriol/Betamethasone Dipropionate Cream in PsoriaticPatients Previously Treated With Foam Vehicle
by: Giacomo Caldarola, et al.
Published: (2025-07-01)

Best Responders and Super-Responders to Calcipotriol and Betamethasone Dipropionate PAD-Cream: A Post Hoc Pooled Analysis of Two Phase 3 Trials
by: Andreas Pinter, et al.
Published: (2025-04-01)

Betamethasone latency period and neonatal hypoglycemia in term infants
by: Lauren A. Buckley, et al.
Published: (2025-12-01)

Topical Steroid Withdrawal: The Challenging Transition from Patient Self-Diagnosis on Social Media to Medical Science and Care
by: Alain Taieb
Published: (2025-04-01)

Atopic dermatitis: Tacrolimus vs. topical corticosteroid use
by: Y. Langa, et al.
Published: (2011-07-01)

Corticosteroid-induced skin damage improved with pimecrolimus cream 1% treatment: a 1-year study in adults with mild to moderate atopic dermatitis
by: Diamant Thaçi, et al.
Published: (2025-12-01)

ATOPIC DERMATITIS: NEW TARGETS OF THERAPY
by: D. Sh. Macharadze
Published: (2014-07-01)

A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendations
by: Matthias Augustin, et al.
Published: (2025-05-01)

Pharmaceutical development specifics of new generic drug products in suspension for injection form on the Betaspan depot (Depos) example
by: O. I. Kachaput, et al.
Published: (2017-08-01)

Cushing’s syndrome in a young woman due to prolonged betamethasone nasal drop use: a case report
by: Mohammadsadra Shamohammadi, et al.
Published: (2025-07-01)

Topical Steroid Withdrawal: Perspectives of Dutch Healthcare Professionals
by: Florence Vroman, et al.
Published: (2025-08-01)

Differences between allergy and dermatology in referral, evaluation, and management patterns for pediatric patients with atopic dermatitis
by: Nicole L. Edmonds, et al.
Published: (2025-12-01)

A study on design & development of betamethasone acetate and betamethasone sodium phosphate extended-release suspension
by: Amit Bansal, et al.
Published: (2025-06-01)

Breaking the cycle: a comprehensive exploration of topical steroid addiction and withdrawal
by: Anish R. Maskey, et al.
Published: (2025-03-01)

NEW FORMULATIONS OF HYDROCORTISONE-17-BUTYRATE IN THE ARSENAL OF MEANS FOR TOPICAL TREATMENT OF ATOPIC DERMATITIS IN CHILDREN
by: N. G. Korotkii, et al.
Published: (2014-07-01)

Observational Study of Corticosteroid Phobia Using the TOPICOP Score among Adults and Caregivers of Children with Atopic Dermatitis in Japan
by: Takeshi Nakahara, et al.
Published: (2025-05-01)

Atopic Dermatitis in Children: Current Clinical Guidelines for Diagnosis and Therapy
by: Leyla S. Namazova-Baranova, et al.
Published: (2016-08-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

Strategies for Selecting Therapeutic Tactics for Reducing Transcutaneous Sensibilisation Risk in Infants with Atopic Dermatitis: Cohort Retrospective Prospective Study
by: Dmitri V. Fedorov, et al.
Published: (2021-03-01)

Atopic dermatitis
by: Stuart Carr, et al.
Published: (2024-12-01)

Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies
by: Melinda J. Gooderham, et al.
Published: (2025-04-01)

Efficacy of dupilumab plus topical corticosteroids in children with atopic dermatitis: A meta‐analysis of randomized controlled trials
by: Li Wang, et al.
Published: (2024-01-01)

Predictors of Topical Corticosteroid Adherence Among Caregivers of Children with Atopic Eczema
by: Liew ELF, et al.
Published: (2025-05-01)

Betamethasone administration as a treatment of choice in local post-tattoo complications
by: O. N. Karymov, et al.
Published: (2020-05-01)

General health and social outcomes 50 years after exposure to antenatal betamethasone: follow-up of a randomised controlled trial
by: Anthony G. B. Walters, et al.
Published: (2024-11-01)

Unilateral Osteonecrosis of the Femoral Head in a Patient with Atopic Dermatitis Due to Uncontrolled Topical Steroid Treatment, a Case Report
by: David Glavaš Weinberger, et al.
Published: (2025-05-01)

Efficacy and safety of intracameral betamethasone versus dexamethasone at the end of phacoemulsification
by: Amira F.Z. El Hewehi, et al.
Published: (2025-04-01)

Pimecrolimus Efficacy and Safety in Management of Children with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01)

Development and Evaluation of in situ eye gel for delivery of gatifloxacin and betamethasone sodium phosphate
by: Fatima Mustafa Ali, et al.
Published: (2025-01-01)

The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema
by: Eva Knöps, et al.
Published: (2024-07-01)

To study the role of tofacitinib and betamethasone pulse in the treatment of vitiligo at a tertiary care centre: an observational comparative study
by: Rashmi Singh, et al.
Published: (2024-01-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Novel biophysical skin biomarkers discriminate topical anti‐inflammatory treatments based on their potential for local adverse effects
by: Simon G. Danby, et al.
Published: (2025-03-01)

Innovative combined topical remedy in the treatment of complicated dermatoses: experience of the application
by: N. V. Kungurov, et al.
Published: (2021-06-01)

Tactics of topical therapy of patients with atopic dermatitis using various dosage forms of topical glucocorticosteroid
by: N. V. Kungurov, et al.
Published: (2021-06-01)

NONSTEROIDAL TOPICAL MEDICATION IN THE THERAPY OF ATOPIC DERMATITIS IN CHILDREN
by: L. S. Namazova-Baranova, et al.
Published: (2012-02-01)

Comparison of analgesic effects between betamethasone and dexamethasone in total knee arthroplasty: a prospective randomized controlled trial
by: Kai Qin, et al.
Published: (2025-07-01)

Rescue Antenatal Corticosteroids in Late Preterm Birth after Completion of the Initial Cycle of Antenatal Corticosteroids during the Early Preterm Period
by: Da Eun Jeong, et al.
Published: (2023-10-01)

Mycosis fungoides unmasked by tralokinumab treatment for atopic dermatitis
by: Sanah Basrai, BA, et al.
Published: (2025-07-01)